Information
Responsable Peptides, Glycoconjugués et Métaux en Biologie
Professeurs invités
Rachel Narehood Austin
Columbia University
Publications
2018
Bioorganic & Medicinal Chemistry,
Volume 26,
p. 1006 - 1015,
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease
Accueil › Publications › Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease

Titre | Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease |
Type de publication | Journal Article |
Nouvelles publications | 2017 |
Auteurs | Kerr F, Sofola-Adesakin O, Ivanov DK, Gatliff J, Gomez Perez-Nievas B, Bertrand HC, Martinez P, Callard R, Snoeren I, Cochemé HM, Adcott J, Khericha M, Castillo-Quan JI, Wells G, Noble W, Thornton J, Partridge L |
Journal | PLOS Genetics |
Volume | 13 |
Fascicule | 3 |
Pagination | e1006593 |
Année de publication | 3/2017 |
DOI | 10.1371/journal.pgen.1006593.s008 |
Importer un fichier | PLoS Genet |
Unité de rattachement:
UMR 7203
Equipe de rattachement 7203:
Equipe 1